This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul 1;1(4):e000080.

doi: 10.1136/esmoopen-2016-000080. eCollection 2016.

AIOM chooses ESMO Open-Cancer Horizons as its official journal: a warm welcome from ESMO Open

Christoph C Zielinski¹, Carmine Pinto²

Affiliations

PMID: 27843630
PMCID: PMC5070276
DOI: 10.1136/esmoopen-2016-000080

Editorial

AIOM chooses ESMO Open-Cancer Horizons as its official journal: a warm welcome from ESMO Open

Christoph C Zielinski et al. ESMO Open. 2016.

. 2016 Jul 1;1(4):e000080.

doi: 10.1136/esmoopen-2016-000080. eCollection 2016.

Authors

Christoph C Zielinski¹, Carmine Pinto²

Affiliations

¹ Department of Hematology , Institute of Hematology and Medical Oncology , Bologna , Italy.
² Reggio Emilia , Italy.

PMID: 27843630
PMCID: PMC5070276
DOI: 10.1136/esmoopen-2016-000080

No abstract available

Keywords: AIOM.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Similar articles

CSCO joins ESMO Open-Cancer Horizons.
Zielinski CC, Wu YL. Zielinski CC, et al. ESMO Open. 2016 Nov 18;1(5):e000120. doi: 10.1136/esmoopen-2016-000120. eCollection 2016. ESMO Open. 2016. PMID: 27933216 Free PMC article. No abstract available.
One year of ESMO Open: Cancer Horizons-where are we going from here?
Zielinski C. Zielinski C. ESMO Open. 2017 Jan 23;1(6):e000153. doi: 10.1136/esmoopen-2016-000153. eCollection 2016. ESMO Open. 2017. PMID: 28848671 Free PMC article. No abstract available.
ESMO Open-Cancer Horizons and the future of oncology.
Zielinski CC. Zielinski CC. ESMO Open. 2016 Jan 18;1(1):e000008. doi: 10.1136/esmoopen-2015-000008. eCollection 2016. ESMO Open. 2016. PMID: 27843582 Free PMC article. No abstract available.
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open-Cancer Horizons pro and con discussion.
Awada A, Gligorov J, Jerusalem G, Preusser M, Singer C, Zielinski C. Awada A, et al. ESMO Open. 2019 Nov 13;4(6):e000565. doi: 10.1136/esmoopen-2019-000565. eCollection 2019. ESMO Open. 2019. PMID: 31798979 Free PMC article. Review.
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion.
Banerjee S, Gonzalez-Martin A, Harter P, Lorusso D, Moore KN, Oaknin A, Ray-Coquard I. Banerjee S, et al. ESMO Open. 2020 Nov;5(6):e001110. doi: 10.1136/esmoopen-2020-001110. ESMO Open. 2020. PMID: 33310779 Free PMC article. Review.

See all similar articles

Cited by

CSCO joins ESMO Open-Cancer Horizons.
Zielinski CC, Wu YL. Zielinski CC, et al. ESMO Open. 2016 Nov 18;1(5):e000120. doi: 10.1136/esmoopen-2016-000120. eCollection 2016. ESMO Open. 2016. PMID: 27933216 Free PMC article. No abstract available.

References

1. I numeri del cancro in Italia (The figures of cancer in Italy). http://www.registri-tumori.it/PDF/AIOM2015/I_numeri_del_cancro_2015.pdf - PubMed
1. Il Libro Bianco dell'oncologia (The White Book of oncology). http://librobianco.aiom.it
1. Linee Guida—Guidelines. http://www.aiom.it/professionisti/documenti-scientifici/linee-guida/1,413,1
1. ‘Raccomandazioni per le indicazioni e le metodiche dei test.’ http://www.aiom.it/professionisti/documenti%2Dscientifici/position%2Dpap...

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations